Parkinson's Treatment
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
88
NCT06189170
Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients
Phase: Early Phase 1
Role: Lead Sponsor
Start: Aug 1, 2024
Completion: Mar 31, 2026
Loading map...